Abbott Diabetes Care, Inc. recalls
Abbott Diabetes Care, Inc. is named on 3 recalls in Recall Relay's records since November 2023, from FDA (6 recalled products: FDA lists each product as its own recall); the most recent was November 24, 2025.
All 6 recalled products, newest first.
-
Class Iofficial
Abbott Diabetes Care, Inc. recalls FreeStyle Libre 3 Plus Sensor REF 72080-01 UDI-DI code: 00357599819002 The FreeStyle Libre 3 Plus sensor is aDue to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
-
Class Iofficial
Abbott Diabetes Care, Inc. recalls FreeStyle Libre 3 Plus Sensor REF 78769-01 UDI-DI code: 00357599843014 The FreeStyle Libre 3 Plus sensor is aDue to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
-
Class Iofficial
Abbott Diabetes Care, Inc. recalls FreeStyle Libre 3 Plus Sensor REF 78768-01 UDI-DI code: 00357599844011 The FreeStyle Libre 3 Plus sensor is aDue to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
-
Class Iofficial
Abbott Diabetes Care, Inc. recalls FreeStyle Libre 3 Sensor REF 72081-01 UDI-DI code: 00357599818005 The FreeStyle Libre 3 sensor is a componentDue to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
-
Class Iofficial
Abbott Diabetes Care, Inc. recalls FreeStyle Libre 3 SensorsUsers of the FreeStyle Libre 3 sensors reported situations where they were receiving erroneously high glucose results. The inaccurate higher glucose values may lead to users calculating higher insulin bolus correctional doses based on inaccurate CGM glucose data. The inaccurate higher glucose values may also contribute to missed or delayed recognition of hypoglycemia, when the sensor incorrectly reports normal or even high glucose values when the actual glucose is trending low or is low. If the hypoglycemia missed by the device occurs acutely, a user may not be able to confirm the actual glucose with a self-monitored blood glucose (BG) and/or administer prompt intervention to raise glucose levels. The over-delivery of insulin and/or the missed or delayed detection of impending or overt hypoglycemia in the worst-case scenario may lead to severe hypoglycemia/hypoglycemic crisis with significant adverse health consequences. Such consequences include central nervous system dysfunction, loss of consciousness, seizure activity and may lead to coma, permanent neurological damage, and death.
-
Class IIofficial
Abbott Diabetes Care, Inc. recalls FreeStyle Libre 3 AppIf using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experienced, due to app not connected, which could impact ability to receive glucose reading/alarms, which could lead to undetected low or high glucose, which could result in delayed treatment: not taking insulin (for high glucose), or not taking glucose (for low glucose) when required.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Abbott Diabetes Care, Inc. or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts